Status:
RECRUITING
Study of the Plasma and Urinary cfDNA of in Kidney Transplant Patients
Lead Sponsor:
Poulet Geoffroy
Collaborating Sponsors:
University Hospital, Rouen
Conditions:
Transplant Rejection
Transplant Kidney
Eligibility:
All Genders
18+ years
Brief Summary
It has been shown that the amount of circulating donor-cell-free DNA increases in patients with transplant rejection. Quantification of single nucleotide polymorphisms (SNPs) present in circulating do...
Detailed Description
Screening Step : As part of routine kidney transplant patient monitoring, humoral or cellular rejection may be suspected when graft function deteriorates, proteinuria increases, or antibodies against...
Eligibility Criteria
Inclusion
- Patients living with a kidney transplant
- Admitted for suspected transplant rejection requiring a renal biopsy (RBB) as an indication
Exclusion
- Patients with cognitive and mental disorders rendering them unable to express their non-opposition to participation in the study
- Not covered by a social security system.
- Under guardianship or guardianship, or under legal protection.
- Patients who have expressed their refusal to participate in the study
Key Trial Info
Start Date :
May 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06910527
Start Date
May 30 2024
End Date
May 31 2026
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Rouen-Bois Guillaume
Rouen, France, 76230